• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE Back to Search Results
Model Number CREP G2
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Non Reproducible Results (4029)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/15/2020
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The initial reporter stated they received a complaint from a doctor who saw an increase in patient values for crep2 creatinine plus ver.2 on the cobas 8000 c (701) module.The reporter stated they saw an increase in 10 units when comparing patient result mean data from october and november.The reporter stated they then tested patient samples from another site using a vitros instrument and saw a difference of around 22 umol/l for all samples.The reporter believes the issue is related to creatinine reagent lot 499631, which they started using (b)(6) 2020.The reporter provided data for seven patient samples with discrepant creatinine results when compared to results measured on the vitros analyzer at the second site.The values measured at the customer site were reported outside of the laboratory.The first sample resulted with a creatinine value of 80 umol/l on the c 701 analyzer, which resulted as 52 umol/l on the vitros analyzer.The second sample resulted with a creatinine value of 88 umol/l on the c 701 analyzer, which resulted as 66 umol/l on the vitros analyzer.The third sample resulted with a creatinine value of 95 umol/l on the c 701 analyzer, which resulted as 78 umol/l on the vitros analyzer.The fourth sample resulted with a creatinine value of 97 umol/l on the c 701 analyzer, which resulted as 79 umol/l on the vitros analyzer.The fifth sample resulted with a creatinine value of 101 umol/l on the c 701 analyzer, which resulted as 82 umol/l on the vitros analyzer.The sixth sample resulted with a creatinine value of 102 umol/l on the c 701 analyzer, which resulted as 83 umol/l on the vitros analyzer.The seventh sample resulted with a creatinine value of 108 umol/l on the c 701 analyzer, which resulted as 87 umol/l on the vitros analyzer.The serial number of the customer's c 701 analyzer is (b)(4).
 
Manufacturer Narrative
It was found during internal investigations that for reagent lot 499631, which was used for comparison results, an absolute positive bias for serum samples of 6-8 ¿mol/l exists.No product specifications are violated and customers can continue to use affected reagent lots.In some cases higher deviations can be observed at customer site, which can be explained by the combination of the test specification (8 ¿mol/l intercept plus 1.05 slope).In addition, it could occur for certain samples (especially in the lower concentration range) that the difference is higher.This effect is sample related.The customer started using a new creatinine reagent lot number and the results are acceptable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREATININE PLUS VER.2
Type of Device
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key11094423
MDR Text Key244805298
Report Number1823260-2020-03438
Device Sequence Number1
Product Code JFY
Combination Product (y/n)N
PMA/PMN Number
K024098
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 02/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberCREP G2
Device Catalogue Number05168589190
Device Lot Number499631
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 12/15/2020
Initial Date FDA Received12/30/2020
Supplement Dates Manufacturer Received12/15/2020
Supplement Dates FDA Received02/16/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-